Wolverine Trading’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$204K Sell
79,400
-20,600
-21% -$53.1K ﹤0.01% 4903
2025
Q2
$270K Buy
100,000
+11,300
+13% +$30.4K ﹤0.01% 3595
2025
Q1
$279K Buy
88,700
+48,700
+122% +$148K ﹤0.01% 3602
2024
Q4
$107K Buy
+40,000
New +$167K ﹤0.01% 4779
2024
Q2
Sell
-59,100
Closed -$317K 4815
2024
Q1
$317K Buy
59,100
+44,500
+305% +$202K ﹤0.01% 3292
2023
Q4
$73.3K Buy
14,600
+2,000
+16% +$6.28K ﹤0.01% 4170
2023
Q3
$21.3K Sell
12,600
-16,200
-56% -$32.5K ﹤0.01% 4316
2023
Q2
$78.3K Buy
28,800
+7,300
+34% +$20.6K ﹤0.01% 3843
2023
Q1
$38K Sell
21,500
-12,200
-36% -$37.9K ﹤0.01% 3892
2022
Q4
$171K Buy
33,700
+20,200
+150% +$111K ﹤0.01% 3220
2022
Q3
$67K Buy
13,500
+2,800
+26% +$12.8K ﹤0.01% 4055
2022
Q2
$40K Sell
10,700
-25,700
-71% -$103K ﹤0.01% 4124
2022
Q1
$214K Buy
36,400
+9,500
+35% +$58.3K ﹤0.01% 4331
2021
Q4
$172K Buy
+26,900
New +$202K ﹤0.01% 4806
2021
Q3
Sell
-20,500
Closed -$298K 6549
2021
Q2
$298K Sell
20,500
-24,800
-55% -$410K ﹤0.01% 4426
2021
Q1
$1.08M Sell
45,300
-18,400
-29% -$477K ﹤0.01% 2659
2020
Q4
$915K Buy
63,700
+31,300
+97% +$301K ﹤0.01% 2482
2020
Q3
$233K Buy
+32,400
New +$323K ﹤0.01% 3696
2020
Q2
Sell
-17,800
Closed -$56K 4854
2020
Q1
$56K Buy
17,800
+7,200
+68% +$36.1K ﹤0.01% 4220
2019
Q4
$41K Buy
+10,600
New +$18K ﹤0.01% 4499

Other funds holding IBRX